Many of the fillers Dr. Bruck uses to treat wrinkles, lines and hollows are hyaluronic acid-based. Hyaluronic acid is one of the main components of our natural connective tissue, and an ingredient used in many of today’s most popular and effective injectable filler brands.
The FDA recently approved a new hyaluronic acid dermal filler
Juvéderm Vollure XC has been approved for the correction of “moderate to severe facial wrinkles and folds, such as nasolabial folds.” It’s said to last as long as 18 months, and that’s about a year longer than many other injectable fillers.
Clinical trials for the new injectable produced many positive results, according to researchers and study participants
- Over half percent of participants saw for up to 18 months
- Over 80 percent were satisfied with results at six months
- Almost 70 percent were still pleased with eight months
Vollure XC uses special Juvederm technology, available in many of its products
Known as Vycross, it’s used in Vollure XC, Voluma XC, and Volbella XC to hold the hyaluronic acid together into a cohesive gel, so it stays together after its injected. A mixture of high and low hyaluronic acid in Vycross technology is used to create a more connected gel, which can be molded, thereby allowing it to effectively lift sunken skin. And Vollure, like other Juvederm injectables, is firm enough to fill in lines, but also soft enough to move naturally with facial expressions.
Less swelling is noted with Juvederm Vollure XC
The new Juvéderm Vollure XC formula produces minimal swelling, and that means a shorter recovery time. The gel also has been shown to last longer that other injectable products, which can mean less overall treatments. The product has been available in Europe since 2013 (called Juvederm Volift), and is now available in the U.S. as Vollure.
Learn more about Juvederm Vollure XC